These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24719372)

  • 1. The perinatal presentation of cardiofaciocutaneous syndrome.
    Wong Ramsey KN; Loichinger MH; Slavin TP; Kuo S; Seaver LH
    Am J Med Genet A; 2014 Aug; 164A(8):2036-42. PubMed ID: 24719372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.
    Myers A; Bernstein JA; Brennan ML; Curry C; Esplin ED; Fisher J; Homeyer M; Manning MA; Muller EA; Niemi AK; Seaver LH; Hintz SR; Hudgins L
    Am J Med Genet A; 2014 Nov; 164A(11):2814-21. PubMed ID: 25250515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial cardiofaciocutaneous syndrome in a father and a son with a novel MEK2 mutation.
    Karaer K; Lissewski C; Zenker M
    Am J Med Genet A; 2015 Feb; 167A(2):385-8. PubMed ID: 25487361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome.
    Siegel DH; McKenzie J; Frieden IJ; Rauen KA
    Br J Dermatol; 2011 Mar; 164(3):521-9. PubMed ID: 21062266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
    Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
    Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.
    Pierpont ME; Magoulas PL; Adi S; Kavamura MI; Neri G; Noonan J; Pierpont EI; Reinker K; Roberts AE; Shankar S; Sullivan J; Wolford M; Conger B; Santa Cruz M; Rauen KA
    Pediatrics; 2014 Oct; 134(4):e1149-62. PubMed ID: 25180280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
    Seemanová E; Zenker M
    Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of a Genetic Diagnosis: Case Presentation of a Preterm Infant With Cardiofaciocutaneous Syndrome.
    Anderson S; Brooks SS
    Adv Neonatal Care; 2015 Aug; 15(4):274-84. PubMed ID: 26225596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual hair findings in a child with cardiofaciocutaneous syndrome.
    Işikay S; Karaer K
    Int J Dermatol; 2019 Mar; 58(3):354-356. PubMed ID: 30094826
    [No Abstract]   [Full Text] [Related]  

  • 11. Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.
    Gross AM; Frone M; Gripp KW; Gelb BD; Schoyer L; Schill L; Stronach B; Biesecker LG; Esposito D; Hernandez ER; Legius E; Loh ML; Martin S; Morrison DK; Rauen KA; Wolters PL; Zand D; McCormick F; Savage SA; Stewart DR; Widemann BC; Yohe ME
    Am J Med Genet A; 2020 Apr; 182(4):866-876. PubMed ID: 31913576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autism traits in the RASopathies.
    Adviento B; Corbin IL; Widjaja F; Desachy G; Enrique N; Rosser T; Risi S; Marco EJ; Hendren RL; Bearden CE; Rauen KA; Weiss LA
    J Med Genet; 2014 Jan; 51(1):10-20. PubMed ID: 24101678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sibling pair with cardiofaciocutaneous syndrome (CFC) secondary to BRAF mutation with unaffected parents-the first cases of gonadal mosaicism in CFC?
    Geoghegan S; King G; Henchliffe J; Ramsden SC; Barry RJ; Green AJ; O'Connell SM
    Am J Med Genet A; 2018 Jul; 176(7):1637-1640. PubMed ID: 29704308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong.
    Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cardiofaciocutaneous Syndrome: From Genetics to Prognostic-Therapeutic Implications.
    Scorrano G; David E; Calì E; Chimenz R; La Bella S; Di Ludovico A; Di Rosa G; Gitto E; Mankad K; Nardello R; Mangano GD; Leoni C; Ceravolo G
    Genes (Basel); 2023 Nov; 14(12):. PubMed ID: 38136934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatological manifestations in cardiofaciocutaneous syndrome: a prospective multicentric study of 45 mutation-positive patients.
    Bessis D; Morice-Picard F; Bourrat E; Abadie C; Aouinti S; Baumann C; Best M; Bursztejn AC; Capri Y; Chiaverini C; Coubes C; Giuliano F; Hadj-Rabia S; Jacquemont ML; Lacombe D; Lyonnet S; Mallet S; Mazereeuw-Hautier J; Miquel J; Molinari N; Parfait B; Pernet C; Philip N; Pinson L; Pouvreau N; Vial Y; Sarda P; Sigaudy S; Verloes A; Cavé H; Geneviève D
    Br J Dermatol; 2019 Jan; 180(1):172-180. PubMed ID: 30141192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome.
    Joyce S; Gordon K; Brice G; Ostergaard P; Nagaraja R; Short J; Moore S; Mortimer P; Mansour S
    Eur J Hum Genet; 2016 May; 24(5):690-6. PubMed ID: 26242988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anesthetic Management of a Pediatric Patient With Cardiofaciocutaneous Syndrome.
    Shionoya Y; Yamamoto M; Sunada K; Nakamura K
    Anesth Prog; 2020; 67(1):45-47. PubMed ID: 32191511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?
    Nowaczyk MJ; Thompson BA; Zeesman S; Moog U; Sanchez-Lara PA; Magoulas PL; Falk RE; Hoover-Fong JE; Batista DA; Amudhavalli SM; White SM; Graham GE; Rauen KA
    Clin Genet; 2014 Feb; 85(2):138-46. PubMed ID: 23379592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXI2: a possible gene contributing to ectodermal dysplasia.
    Kurban M; Zeineddine SB; Hamie L; Safi R; Abbas O; Kibbi AG; Bitar F; Nemer G
    Eur J Dermatol; 2017 Dec; 27(6):641-645. PubMed ID: 29165300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.